PLYMOUTH MEETING, Pa., and SEOUL, Korea, Sept. 4 (Korea Bizwire) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and GeneOne Life Science (KSE: 011000) today announced they have dosed the first patient in a Phase 1 study designed to evaluate a preventive vaccine against hepatitis C infection. Recruitment has already begun in South Korea, where GeneOne is responsible [...]
SEOUL, Sept. 18 (Korea Bizwire) – As Sovaldi, a new drug for the hepatitis C virus developed by US-based biotechnology company Gilead, has been approved by the Ministry of Food and Drug Safety of Korea, speculation is mounting over how much it will cost in Korea. The drug is currently being sold for US$1,000 a pill [...]
SEOUL, Aug. 20 (Korea Bizwire) – Sharing razors with others can raise the possibility of contracting the hepatitis C virus (HCV) by up to 3.3 times, according to a recent study. Piercing, tattooing and having multiple sex partners also raised the infection rate by up to six times. HCV is contracted via blood and body fluids, [...]